DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
13.90
+0.85 (6.51%)
At close: Dec 5, 2025, 4:00 PM EST
14.00
+0.10 (0.72%)
After-hours: Dec 5, 2025, 6:36 PM EST
DBV Technologies Employees
As of December 31, 2024, DBV Technologies had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees increased by 5 or 4.76% compared to the previous year.
Employees
110
Change (1Y)
5
Growth (1Y)
4.76%
Revenue / Employee
$50,018
Profits / Employee
-$1,137,573
Market Cap
474.46M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DBVT News
- 24 days ago - DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years - GlobeNewsWire
- 4 weeks ago - DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 4 weeks ago - DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer - GlobeNewsWire
- 5 weeks ago - DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors - GlobeNewsWire
- 5 weeks ago - DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting - GlobeNewsWire
- 5 weeks ago - DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq - GlobeNewsWire
- 2 months ago - DBV Technologies Announces Resignation of Board Member - GlobeNewsWire
- 3 months ago - DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq - GlobeNewsWire